Common experiences during week 1-2 include slight changes in appetite patterns, mild nausea that differs from what tirzepatide caused (more constant and less meal-related), and subtle shifts in bowel habits
1810): glucagon receptors also couple to Gi protein in human atrial myocytes, and Gi upregulation in the cardiomyocyte inhibits cAMP formation and Gs-coupled signal transduction, so glucagon action in the chronically failing heart "may theoretically be impaired." Two limits on how far that carries: the condition Petersen describes is heart failure , not obesity or sedentary metabolic dysfunction, and the impairment is offered as a hypothesis, not an observation
Ozempic can cause the body to slow digestion, which can in turn cause or exacerbate stomach paralysis symptoms
This retrospective cohort study evaluated TTR 6 months before and after GLP-1 RA initiation using RWD from the TriNetX Research Network
A detailed knowledge of incretin physiology and pathophysiology will be a prerequisite for designing more effective incretin-based drugs for metabolic diseases.